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MRS water resonance frequency in childhood
brain tumours: a novel potential biomarker of
temperature and tumour environment
Ben Babourina-Brooksa,b*, Martin Wilsona,b, Theodoros N. Arvanitisb,c,
Andrew C. Peeta,b and Nigel P. Daviesa,d
1H MRS thermometry has been investigated for brain trauma and hypothermia monitoring applications but has not been
explored in brain tumours. The proton resonance frequency (PRF) of water is dependent on temperature but is also
inﬂuenced by microenvironment factors, such as fast proton exchange with macromolecules, ionic concentration and
magnetic susceptibility. 1H MRS has been utilized for brain tumour diagnostic and prognostic purposes in children;
however, the water PRF measure may provide complementary information to further improve characterization. Water
PRF values were investigated from a repository of MRS data acquired from childhood brain tumours and children with
apparently normal brains. The cohort consisted of histologically proven glioma (22), medulloblastoma (19) and control
groups (28, MRS in both the basal ganglia and parietal white matter regions). All data were acquired at 1.5T using a short
TE (30ms) single voxel spectroscopy (PRESS) protocol. Water PRF values were calculated using methyl creatine and total
choline. Spectral peak amplitude weighted averaging was used to improve the accuracy of the measurements. Mean
PRF values were signiﬁcantly larger for medulloblastoma compared with glioma, with a difference in the means of
0.0147ppm (p< 0.05), while themean PRF for gliomawas signiﬁcantly lower than for the healthy cohort, with a difference
in the means of 0.0061ppm (p<0.05). This would suggest the apparent temperature of the glioma group was ~1.5 °C
higher than themedulloblastomas and~0.7 °C higher than ahealthy brain. However, the PRF shiftmaynot reﬂect a change
in temperature, given that alterations in protein content, microstructure and ionic concentration contribute to PRF shifts.
Measurement of these effects could also be used as a supplementary biomarker, and further investigation is required. This
study has shown that the water PRF value has the potential to be used for characterizing childhood brain tumours, which
has not been reported previously. © 2014 The Authors. NMR in Biomedicine published by John Wiley & Sons, Ltd.
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INTRODUCTION
Cancer is the most common cause of death in children after infancy,
and, whilst signiﬁcant advances have been made, the rate of im-
provement in survival is decreasing. Novel techniques are required
to continually improve the outcome of cancer patients. One tech-
nique is 1HMRS, which is a powerful non-invasive tool for the assess-
ment of childhood brain tumours throughMRS pattern classiﬁcation
(1). A complementary analysis technique, which may provide addi-
tional information, is 1H MRS thermometry. 1H MRS thermometry
is a non-invasive method to measure brain temperature changes
and provide information about the tissue microenvironment.
Temperature has been shown to be an important factor in
characterizing tumours, with changes in temperature compared
with surrounding tissue being observed for different tumour
types (2). Infrared thermal imaging has been used as a screening
tool for malignant breast tumours (3) and for intra-operatively
delineating the margins of brain tumours (2). Temperature rises
have been attributed to abnormalities in vasculature leading to
hypoxia and abnormal energy metabolism (4,5), whilst decreases
may be associated with the presence of necrosis. Hypoxia has
been shown to increase treatment resistance in brain tumours,
stimulating interest in non-invasive markers of hypoxia to aid
prognosis and treatment stratiﬁcation. The link between hypoxia,
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temperature and metabolism provides an opportunity for
non-invasive MR thermometry in combination with MRS to
increase the clinical utility of routine MRI scans of childhood
cancer at diagnosis and follow-up. Many children with brain
tumours do not undergo a biopsy, or have residual masses
that need to be monitored, making non-invasive methods
for the assessment of the tumour microenvironment particu-
larly attractive.
MRS thermometry, using the water proton resonance frequency
(PRF), is calibrated against a temperature independent referenceme-
tabolite(s). The water PRF shift is linearly dependent on temperature,
between 20 and 50 °C, with a coefﬁcient of~0.01ppm°C1 (6,7).
The water PRF has also been found to be affected by the chemical
environment, including ionic concentration, protein concentration
(chemical exchange) (8,9) and magnetic susceptibility (10–12). These
factorsmay signiﬁcantly affect thewater PRF, and hence the apparent
temperature measure; however, the sensitivity of the PRF to the
microenvironment could also be used as a supplementary biomarker.
Investigating the microenvironment effect is therefore of interest.
Commonly, N-acetylaspartate (NAA) is used as a metabolite
reference due to its high signal in brain tissue; however, NAA signal
in brain tumours is signiﬁcantly reduced and therefore not suitable.
Total choline (Cho) and methyl creatine (Cr) are prominent singlet
peaks in brain tumours and healthy brain, and therefore more
appropriate reference metabolites (12). Cho and Cr have been used
individually for brain temperature measures (13–15); however,
individual metabolite references can incur error in PRF shift
measurement. The error can be random, e.g. low signal to noise ratio
(SNR) and ﬁnite line-width, and non-random, e.g. overlapping nearby
metabolite peaks, which leads to ﬁtting error. Combining multiple
metabolite peak references by using an amplitudeweightingmethod
signiﬁcantly reduces the random errors (13).
This technique has been shown to be an effective tool for brain
temperature mapping (16–18). The non-invasive measurement
of brain temperature is favourable for a number of applications where
MRS thermometry could be implemented: brain trauma (19), stroke
(20) and hypothermia monitoring (14,21). Both non-invasive tempera-
ture and tumour environment measures could aid in tumour diagno-
sis; however, brain tumour water PRF measures have been relatively
unexplored, especially in children. In one study investigating
tumour MRS thermometry the authors show signiﬁcant tempera-
ture differences among adult brain tumour types (22).
The aim of this study was to investigate the diagnostic poten-
tial of the water PRF shifts of paediatric brain tumours on a
clinical 1.5 T scanner. Speciﬁcally, two common paediatric tumour
types (medulloblastomas and gliomas) and deep grey matter
(basal ganglia, BG) and white matter (WM) regions in apparently
healthy paediatric brain, were investigated and compared. This
was achieved through measuring water PRF differences relative
to Cho, Cr and peak amplitude weighting methods.
EXPERIMENT
Patients
Patients under 16 years of age undergoing MRI, prior to diagno-
sis, for a suspected cerebellar tumour, between 1 September
2006 and 31 July 2011 were eligible for this study. A retrospec-
tively selected patient group of 44 children were studied before
treatment, which included major surgical resection with the
diagnosis conﬁrmed by histopathology. All patients were chosen
based on their visually prominent Cho and Cr referencemetabolite
peaks. This study’s patient cohort, after quality control,
consisted of 22 glioma tumours (12 male, 10 female; mean
(standard deviation, SD) age 9.1 (4.3) years; 14 grade 1, six grade
2, one grade 3 and one grade 4) and 19medulloblastomas (13male,
six female; mean (SD) age 6.6 (3.4) years, 19 grade 4). Tumours were
graded using the WHO grading system (2007). All medulloblasto-
mas were located in the posterior fossa, and the glioma tumours
were mostly in the posterior fossa but ﬁve were supratentorial
tumours. Tumours were grouped into gliomas andmedulloblastomas
for comparison purposes.
A control group was selected consisting of 28 children (22 male,
six female; mean ± SD age 6.2 ± 4.5 years), who underwent
investigations for a suspected metabolic disorder but both MRI
and MRS were deemed normal in appearance by an experi-
enced radiologist and none of the cases went on to have a
metabolic disorder conﬁrmed. The control group data were
acquired in two consistent brain regions containing BG grey
matter and parietal WM. Ethics approval for the study was
granted by the local research ethics committee, and informed
parental consent was also obtained.
Data acquisition
All data were taken from studies using a 1.5 T scanner (Siemens
Symphony Magnetom, NUM4). Patients were scanned as part
of an MRS multicentre study, unoptimized for MR thermometry.
The protocol included T1- and T2-weighted images of the brain
and MRS and T1-weighted images of the head and spine after
administration of contrast agent. MR spectra were acquired using
a water suppressed chemical-shift-selective point resolved single
voxel spectroscopy (PRESS) sequence (TE = 30ms, TR = 1500ms)
with an acquisition bandwidth per point of 1.024Hz. Cubic voxels
with 2 cm or 1.5 cm length were used and 128 or 256 repetitions
were acquired, respectively. Water reference spectra with eight
repetitions were acquired for eddy current correction and as an
internal reference for quantifying metabolite concentrations. The
conventional images were used to delineate the margins of the
primary tumour and enable the placement of the MRS voxel within
the solid-appearing component of the tumour (Fig. 1). The risk of
lipid contamination of the MRS signal from scalp or other fatty
tissue was minimized by avoiding close proximity to these areas
during positioning of the voxel.
MRS processing
Spectra were analysed in the jMRUI (jMRUI, Java Magnetic Reso-
nance User Interface) software package using the AMARES tool
(23). The Cr and the Cho peak were chosen as references since
they were prominent in all tumour and healthy spectra. Mean
spectra of the groups, with SD, were generated using MATLAB
and normalized by the sum of the absolute real values in the
frequency domain (0.5–4 ppm range) (see Figure 3 later).
The PRF of water (δH2O), choline (δCho) and creatine (δCr) were
determined in the frequency domain by correcting the zero
order phase manually and ﬁtting individual peaks with a
Lorentzian proﬁle. Chemical shifts of 4.68 ppm, 3.03 ppm and
3.22 ppm were used as initial estimates for ﬁtting the H2O, Cr
and Cho peaks respectively. Since NAA was not often readily
detected in all tumour spectra, only water PRF shifts relative to
Cr, δ(H2O – Cr), and Cho, δ(H20 – Cho), were determined for each
spectrum (Fig. 2).
MRS WATER RESONANCE FREQUENCY IN CHILDHOOD BRAIN TUMOURS
NMR Biomed. 2014; 27: 1222–1229 © 2014 The Authors. NMR in Biomedicine published by John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/nbm
1223
To standardize the inherently different metabolite shifts,
δ(H20 – Cho)≈ 1.46 ppm and δ(H2O – Cr)≈ 1.65 ppm, standardized
water PRF values were calculated using Equation [1]. Converting
the PRF shift to temperature may also provide a standardized
value; however, an absolute temperature value requires calibra-
tion for each tissue structure based on other factors affecting
the PRF (9), e.g. fast proton exchange. Therefore, the calculated
water PRF value was deemed more appropriate as the quantity
to report in this study.
The water PRF (δ W(metabolite)) was calculated by summing the
measured δ(H2O – metabolite) and a set constant PRF value for the
reference metabolites, Cho = 3.22 ppm, Cr = 3.03 ppm, labelled
δset metabolite in Equation [1]. This value relates to the water
chemical shift, allows comparison betweenmetabolite references
and reduces bias arising from the shift difference when cal-
culating amplitude weighted PRF shifts.
δw metaboliteð Þ ¼ δ H2Ometaboliteð Þ þ δset metabolite [1]
The error in δW(metabolite) is inversely proportional to the refer-
ence peak amplitude; therefore, an average value for multiple
reference metabolites weighted by the square of the reference
peak amplitude provides a more precise PRF measure (13,24).
Therefore, reference peak amplitude-squared weighting (A2w)
was used (12). The A2w equation is
δ2AW ¼
δW Choð ÞA2Cho þ δW Crð ÞA2Cr
 
A2Cho þ A2Cr
[2]
The mean (SD) of the water PRF (δW(metabolite)) and A
2
w water
PRF (δΑ
2
W) were calculated for each spectrum.
SNR was deﬁned as the reference metabolite signal amplitude
divided by the SD of the noise. Individual peak, Cho and Cr, SNRs
were calculated and compared for all groups (see Table 1 later).
Quality control
Two quality control criteria were applied to the spectra: (1)
FWHM of the water reference peak less than 10Hz and (2) SNR
Figure 1. Voxel placements of a grade 1 glioma (left), BG (centre) and WM (right) regions in a patient and two different controls, respectively.
Figure 2. A low grade glioma tumour spectrum depicting the water
peak to reference metabolite chemical shift measure.
Table 1. Individual reference peak, Cho and Cr, SNR values
and SDs for the studied patient groups
Patient group Cho mean SNR (SD) Cr mean SNR (SD)
Medulloblastoma 9.1 (4.4) 3.4 (1.4)
Glioma 6.5 (2.9) 3.6 (1.7)
BG 3.6 (0.9), 4.8 (0.9)
WM 3.9 (1.2) 3.3 (0.8)
B. BABOURINA-BROOKS ET AL.
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of the metabolite spectra greater than four. Spectrum ﬁts
were individually screened for artefacts and baseline anomalies.
Individual metabolite ﬁts produced by AMARES were also
inspected to conﬁrm that they corresponded to the features
seen in the tumour spectra. In particular the Cho and Cr, at PRFs
of 3.22 ppm and 3.03 ppm respectively, were assessed. Based
on the selection criteria only three of the selected spectra
were rejected.
Statistical analysis
Comparisons of the mean PRF between the four groups, medul-
loblastomas, gliomas, control BG and WM, were made using pair-
wise two-tailed Student t-tests. The threshold for signiﬁcance
was taken as p< 0.05. A power analysis calculation showed that
the 19 samples would detect a large effect size (Cohen d=0.68)
for a two-tailed, paired t-test at a signiﬁcance level of 0.05 with a
power of 0.80.
RESULTS
The mean (SD) water line-width and metabolite SNR across the
accepted tumour cases were 5.1 (1.6) Hz and 8.0 (4.5), respectively.
The mean spectra had distinct Cho and Cr peaks in both
healthy and tumour cases (Fig. 3). The NAA peak was poorly
deﬁned in tumour spectra due to its low signal intensity and
overlap with signals from glutamate, glutamine and macromole-
cules increases ﬁtting error. Cho and Cr were used as metabolite
references to give the most accurate PRF shift for groups chosen.
The individual peak SNR values (SD) are shown in Table 1.
The average Cho/Cr ratio was 1.54 (2.35), 2.52 (2.64), 1.32 (0.23)
and 0.85 (0.21) for the medulloblastoma, glioma, BG and WM,
respectively. Therefore, the spectral peak amplitude-squared
weighting of the water PRF was substantially weighted towards
the Cho peak value, except in the WM group.
Spectral peak amplitude-squared weighted water PRF shift
The δA2W mean (SD) values for the medulloblastoma, glioma, BG
and WM groups were 4.689ppm (0.011ppm), 4.674ppm
(0.014ppm), 4.684ppm (0.0083ppm) and 4.683ppm (0.013ppm),
respectively (Fig. 4). The medulloblastoma δA2W was signiﬁcantly
higher than the δA2W of the glioma group, with a difference of
0.0147ppm, p< 0.01. However, it was similar to that in the BG or
WM group, p~0.09, with differences of 0.0053ppm and
0.0061ppm, respectively. The glioma group δA2W was 0.0094ppm
lower than for the BG, p< 0.01, and 0.0086ppm lower than the
WM group value, p< 0.05.
Individual metabolite based water PRF
Comparison of the individual water PRF shifts, δW(Cho) and δ W(Cr)
(Fig. 5) shows a similar trend, across the groups, to the
amplitude-squared weighted results (Fig. 4). However, the SD
was generally larger for the water PRF shifts calculated using
individual metabolite references. Comparing the two individual
Figure 3. Mean metabolite spectra of tumour and control brain cohorts: (a) control BG, (b) control WM, (c) glioma and d) medulloblastoma regions.
Standard deviations are shown via grey bands.
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metabolite reference plots, the Cr plot had consistently reduced
mean PRF values across groups; however, only the medulloblas-
toma group PRF difference was signiﬁcant, p< 0.05. The group
SDs were similar for each individual metabolite reference, except
for the glioma group, in which the SD for δ W(Cr) was signiﬁcantly
larger, p< 0.05.
Apparent temperature
Apparent temperature conversions were based on healthy piglet
brain temperature calibrations, which were reported to repre-
sent central brain temperature in humans well, for Cho and Cr
individually (8). The mean apparent temperatures were 35.8 °C,
37.2 °C, 36.3 °C and 36.5 °C for the medulloblastoma, glioma, BG
and WM groups, respectively, using the Cho metabolite
reference. When Cr was used as the reference the results were
35.7 °C, 36.4 °C, 35.5 °C and 35.6 °C for the medulloblastoma,
glioma, BG and WM groups, respectively.
The apparent temperature mean values were different between
the tumour groups and in gliomas compared with grey and white
matter in the control group, p< 0.05. The mean apparent tem-
perature was signiﬁcantly lower in the medulloblastoma group
compared with the control group, but only when using Cho as
the reference metabolite, p< 0.05. The apparent temperature
using Cho as the reference metabolite was always higher than that
calculated using Cr as the reference, although for the medulloblas-
toma group the values were comparable.
DISCUSSION
In this study, the PRF of water was investigated based on two
reference metabolites, Cho and Cr. The δA2W shifts were ob-
served for different cohorts consisting of two childhood brain
tumour types and two brain regions in a group of children with
apparently normal brain spectra as control groups. Signiﬁcant
differences were observed between the tumour groups and
between the tumour and control groups. The δA2W was signiﬁ-
cantly different for the medulloblastoma and glioma tumour
types in this study; however, elucidating the mechanisms
underlying the shift difference will be essential to unlocking
the technique’s potential.
The results of this study are based on clinical data taken from
routine MRS scans. The measure of the water PRF shift is there-
fore a free measure complementary to MRS metabolite concen-
trations and proﬁling.
Spectrum-peak amplitude-squared weighted water PRF shift
The control cohort δA2W was not signiﬁcantly different from the
initial estimate of 4.68 ppm. However, the PRF shift of the tumour
groups compared with the control cohort was higher for the
medulloblastoma group and lower for the glioma group. As-
suming that a major contribution to the PRF change is tempera-
ture, the water PRF shift of the medulloblastoma group would
imply a lower mean temperature than for the glioma group.
Models of temperature change due to metabolic activity and
blood ﬂow have been investigated in healthy brain (24). Mean
temperature differences of ~0.3 °C were calculated between
tissue and blood temperature in resting state healthy brain.
However, tumour vasculature and metabolic rates are different,
hence a larger temperature difference may be seen depending
on the tumour physiology and metabolism. Metabolic rate and
blood ﬂow may therefore be a major cause for temperature
differences between tumour types. A difference in mean tem-
perature may arise from differences in cellularity, necrosis,
hypoxia and vasculature between the two tumour groups. High
cellularity with increased metabolic rate and hypoxic regions
(high metabolism and low blood ﬂow) may be expected to lead
to higher average temperature, while necrotic regions and
increased vascularity may be expected to lead to lower average
temperature due to reduced metabolism and increased thermal
transportation from the tumour respectively. Medulloblastomas
are highly cellular compared with low grade gliomas, and they
have relatively small amounts of necrosis and hypoxia compared
with high grade gliomas (26). Necrotic regions were also avoided
as much as possible in the placement of the spectroscopy
regions of interest. Therefore, active cell density and vascularity
are expected to be the main drivers for the possible temperature
differences seen in this study. A lower temperature in medullo-
blastomas could be explained by increased thermal transport
effects outweighing any increased metabolic activity (26,27).
Indeed, in comparison with the glioma group, consisting of
mainly low grade tumours, the medulloblastomas are known to
have increased vasculature that could provide a cooling effect
(28). However, due to competing drivers for temperature change
Figure 5. Mean (standard error) choline and creatine based water PRF
values for the patient cohorts. Means with different letters are signiﬁ-
cantly different (p< 0.05, A–B p< 0.01); A,C was not signiﬁcantly different
from A or C.
Figure 4. Mean (standard error) amplitude-squared weighted water PRF
values for the patient cohorts. Means with different letters are signiﬁ-
cantly different (p< 0.05, A–B p< 0.01).
B. BABOURINA-BROOKS ET AL.
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in the tumour groups and the sensitivity of the water PRF to
other factors, it is unlikely that all of the difference in water
PRF observed can be explained by temperature effects.
An increase in temperature lengthens the hydrogen bonding
between molecules, which increases the electron shielding,
thereby decreasing the water PRF (29,30). The temperature mea-
sure in tumours may be of importance, particularly if a link with
hypoxia can be veriﬁed. Hypoxic tumours resist radiotherapy
treatment, and non-invasive measures of hypoxia would be
advantageous for treatment stratiﬁcation. However, changes in
the water PRF may also relate to tissue environment differences.
The difference in the water PRF shift observed could have signif-
icant contributions from chemical environmental effects such as
protein and ionic concentration, cellular structure, tissue water
content, pH (7,9,17) and magnetic susceptibility effects (11).
Such environmental factors can be quite different between
tumour types, hence associated water PRF changes could pro-
vide a unique measure to aid characterization. However, eluci-
dating the individual contributions of temperature and tissue
environmental factors to the water PRF shift requires further
investigation.
The water PRF shift has been shown to be directly propor-
tional to protein concentration in vitro (8,9). This is due to fast
chemical exchange between free water and bound macromo-
lecular protons. The magnitude of this effect on water PRF
in vivo will depend on water content, macromolecular concentra-
tion and microstructure. An increase in the fast chemical
exchange effect would result in an increased water PRF and a
decreased apparent temperature. In medulloblastomas, necrosis
is relatively low and cellularity is high compared with the mainly
low grade gliomas. This is likely to mean increased fast chemical
exchange effects in the medullobastomas and consequently an
increased water PRF, which could explain the results of this
study. The BG and WM have similar PRF values, as expected
due to good thermoregulation in the brain (25,31) and similar
protein concentrations and water contents (32,33).
Ionic concentration has been shown to decrease the water
PRF shift (9), which mimics an increased temperature and op-
poses the fast chemical exchange effect. Ionic concentrations
in tumour and healthy tissue have been measured using 23Na
spectroscopy (34). The results are a measure of the combined
extracellular and intracellular ionic concentrations, which is rele-
vant to 1H MRS as it also measures the average of both compart-
ments. Adult malignant glioma tumour tissue was found to have
a sodium concentration of 103 (36) mM/kg, compared with
healthy tissue, which had approximately 65 (9) mM/kg. There-
fore, this increased ionic concentration would result in an
increased apparent temperature. In this study, a reduced PRF
shift was seen for the gliomas compared with healthy tissue,
which may have substantial contributions from increased
temperature and ionic concentration. In adult healthy brain,
GM and WM groups, the ionic concentrations have been shown
to be similar (34). Childhood tumour types may have signiﬁcantly
different ionic concentrations but the authors are unaware of
any studies that have investigated this.
Other potential explanations for the difference in water PRF
seen between the tumour groups include magnetic suscep-
tibility effects due to tissue heterogeneity on both macroscopic
and cellular scales. Where the water and metabolite compart-
ments are not perfectly co-located, it is possible that such effects
may not be adequately accounted for simply by referencing to
temperature insensitive metabolite peaks. On a macroscopic
level this may be caused by chemical shift displacement or by
signiﬁcant amounts of cystic or necrotic material within the
voxel. Microscopic susceptibility effects on the water PRF may
result from a combination of anisotropic tissue microstructure
and differences in the cellular distribution of the Cho and Cr
metabolites and the water (10). However, this study was under-
taken at a ﬁeld strength of 1.5 T and care was taken to avoid
cystic or necrotic areas within the voxels, hence both the
macroscopic and microscopic magnetic susceptibility effects
are thought to have had a small or negligible impact in this
study. However, such effects may be more signiﬁcant at higher
ﬁeld strengths and should be considered in future studies.
pH may also be of importance for water PRF measures in vivo,
as tumour extracellular space is more acidic compared with
healthy tissue (35); however, several in vitro studies have shown
no signiﬁcant effect of pH on water PRF (7,17,36,37).
Individual reference metabolite based water PRF
While spectrum peak amplitude-squared weighting of multiple
reference metabolites provides improved accuracy and precision
of the water PRF value, the measurements based on each indi-
vidual reference metabolite may contain interesting information
and reveal subtle differences between the groups. δW(Cr) values
were generally lower than δW(Cho) for all groups (Fig. 5). Both
reference peaks have contributions from more than one metab-
olite; however, at 1.5 T they are unresolved and form a single
peak. Each contributing metabolite has a slightly different PRF
and therefore may affect the average PRF of the reference me-
tabolite. Davies et al. used high resolution magic angle spinning
spectroscopy to investigate the free choline (δ~ 3.205 ppm),
phosphocholine (PC, δ~3.225 ppm) and glycerophosphocholine
(GPC, δ~3.233 ppm) contributions to Cho in childhood tumour
tissue (1). The contribution to the Cho PRF from PC is large in
medulloblastomas and signiﬁcantly less in gliomas. The GPC
contribution is small in medulloblastomas but large in gliomas.
The free choline contribution appears to be small for both
tumour groups. Since we used a ﬁxed reference value of
3.22 ppm for Cho, this would result in an apparent water PRF
difference between medulloblastomas and gliomas, which is
estimated to be ~0.0035 ppm. This could explain approximately
20% of the difference in water PRF between the tumour groups
in this study.
Total creatine (Cr) comprises creatine and phosphocreatine;
however, the signals are only 0.002 ppm apart and their concentra-
tion across cohort groups is similar (1); therefore, this would not
signiﬁcantly affect the water PRF measurement. Cr would seem
to be a more consistent reference metabolite; however, compared
with Cho the concentration in tumours is lower and the variation in
concentration is larger, even within the same tumour group. This
promotes larger relative contributions from nearby metabolites
and noise, increasing measurement error. This was reﬂected in
the larger SDs observed for the Cr referenced water PRFs than for
Cho referenced water PRFs in this study. Individual reference
metabolite chemical shift differences were also seen in healthy
piglet brain by Cady et al. (13). Their results were consistent with
a lower PRF shift for Cr metabolite reference measures. This was
attributed to the presence of multiple metabolites in the Cho peak;
however, this does not explain all the differences in this work.
Further work is required to understand the difference observed
in water PRF when using the two individual reference metabolites.
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Apparent temperature
The authors are not aware of any studies reporting brain tumour
temperature differences in children in the literature; however,
one study investigated this in adults. Their study found a signif-
icant difference between two adult brain tumour groups, glioma
and meningioma (22). The mean low grade glioma apparent
temperature (37.0 °C) found in this study was different from their
result, 36.0 °C. This can be explained by their use of a different
single reference metabolite, NAA, a different calibration equation (7)
and biological differences in the tumour types in adults com-
pared with children. NAA concentration is relatively small in a
range of tumour types, which may introduce errors in peak
ﬁtting and therefore PRF shift. By using two metabolites and
averaging the shifts, the PRF error due to small metabolite
concentration may be reduced (13).
Overall, the apparent temperature is a combination of actual
temperature and micro-environmental effects as previously de-
scribed. The inﬂuence of the micro-environmental effects on the
water PRF measure is of great interest due to the importance of
the tumour micro-environment for characterizing tumour types
and predicting response to treatment.
Limitations
The selection criteria were based on prominent Cho and Cr
peaks, which created a selection bias towards higher SNR
spectra. A prospective study including consecutive brain tumour
patients to evaluate the effect of varying spectral quality would
be of interest. The control group had apparently normal spectra,
but there may be subtle differences between our control group
and healthy volunteers; however, the chance of this signiﬁcantly
affecting the results presented here is low.
The power analysis showed the number of patients included
was sufﬁcient to detect signiﬁcant differences between tumour
groups. The SDs, which reﬂect both the measurement uncer-
tainty and the between-subject variability for each group, were
small enough to observe differences between most groups,
although the medulloblastoma group was not signiﬁcantly dif-
ferent from the healthy groups. This difference may become
signiﬁcant with higher spectral resolution and/or SNR to reduce
measurement uncertainty, particularly for the lower amplitude
Cr reference. Such improvements in metabolite-referenced
water PRF measurements could be achieved by performing
studies at higher ﬁeld strength, without a necessary increase in
acquisition time. Future studies should take advantage of the
increasing use of 3 T scanners for childhood brain tumour
imaging to exploit this expected increase in precision, while
accounting for the associated increase in magnetic susceptibility
and chemical shift displacement effects.
CONCLUSION
The water PRF shift was shown to differ between two major
paediatric tumour types, gliomas and medulloblastomas, based
on mean cohort values. This suggests that the water PRF has
the potential to characterize tumours. Further work may identify
the separate contributions from temperature and micro-
environmental effects on the water PRF measure, which could
provide further aid in diagnosis and prognosis for childhood
brain tumours.
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